基本信息
views: 0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
I am currently leading a national clinical trial for patients with relapsed Hodgkin lymphoma. I also serve as the principal investigator for numerous clinical trials at NYU Langone involving a range of different therapies, including targeted therapy, immunotherapy, and radiation therapy. Many of these clinical trials explore innovative methods of combining new targeted or immune-based therapies with existing therapies to find new ways to control lymphoma, while maximizing patients’ quality of life and minimizing side effects. I also collaborate with basic scientists to create the next generation of therapeutic approaches for the management of lymphoma.
I am on the lymphoma committee of the ECOG-ACRIN Cancer Research Group, a cooperative group made up of the Eastern Cooperative Oncology Group and the American College of Radiology Imaging Network. I have also been invited to serve on multiple committees of both the American Society of Hematology and the American Society of Clinical Oncology. I have received research grants for my work from the National Cancer Institute, the American Cancer Society, and the Lymphoma Research Foundation.
I am on the lymphoma committee of the ECOG-ACRIN Cancer Research Group, a cooperative group made up of the Eastern Cooperative Oncology Group and the American College of Radiology Imaging Network. I have also been invited to serve on multiple committees of both the American Society of Hematology and the American Society of Clinical Oncology. I have received research grants for my work from the National Cancer Institute, the American Cancer Society, and the Lymphoma Research Foundation.
Research Interests
Papers共 6 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn